Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0H6DL
|
||||
Former ID |
DNC006098
|
||||
Drug Name |
1,3,5-triphenylimidazolidine-2,4-dione
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527995] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H16N2O2
|
||||
Canonical SMILES |
C1=CC=C(C=C1)C2C(=O)N(C(=O)N2C3=CC=CC=C3)C4=CC=CC=C4
|
||||
InChI |
1S/C21H16N2O2/c24-20-19(16-10-4-1-5-11-16)22(17-12-6-2-7-13-17)21(25)23(20)18-14-8-3-9-15-18/h1-15,19H
|
||||
InChIKey |
YEGAYNNVHYHYEO-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 1 | Target Info | Inhibitor | [527995] | |
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.